Experimental study on TGF-1-mediated CD147 expression in oral submucous fibrosis
Experimental study on TGF-1-mediated CD147 expression in oral submucous fibrosis
复制标题
TGF-1介导的CD147表达在口腔粘膜下纤维化中的实验研究
DOI:
10.1111/odi.12845
复制
发表时间:
2018-09-01
期刊:
影响因子:
3.8
通讯作者:
Su, T.
中科院分区:
文献类型:
--
作者:
Wang, W.;Xiong, H.;Su, T.
T ObjectiveAlthough previous evidence indicates that CD147 is closely involved in the progression of organ fibrosis and various signaling pathways have been proven to regulate its expression, the role of CD147 in oral submucous fibrosis (OSF) remains largely unknown.MethodsIn this study, we investigated the expression of CD147 and transforming growth factor 1 (TGF-1) in human samples of an OSF tissue array by immunohistopathology. Pearson's correlation analysis was conducted to explore the correlation between CD147 and TGF-1. Immunofluorescence and Western blotting were used to investigate to levels of CD147 in Human Oral Keratinocytes (HOKs) followed by TGF-1 or LY2157299, an inhibitor of TGF-1 receptor and arecoline stimulation.ResultsWe found that CD147 was highly expressed in both HOKs and the fibrotic oral mucosa and that this expression was correlated with TGF-1 expression. Additionally, CD147 levels were significantly associated with the fibrosis stage. The TGF-1 signaling pathway was found to be mainly responsible for CD147 up-regulation after arecoline treatment whereas inhibition of TGF-1 down-regulated CD147 expression.ConclusionOur findings suggest arecoline promotes CD147 expression via the TGF-1 signaling pathway in HOKs, whereas overexpression of CD147 may promote OSF progression.